Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 4
2022 5
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity.
De Matteis S, Dicataldo M, Casadei B, Storci G, Laprovitera N, Arpinati M, Maffini E, Cortelli P, Guarino M, Vaglio F, Naddeo M, Sinigaglia B, Zazzeroni L, Guadagnuolo S, Tomassini E, Bertuccio SN, Messelodi D, Ferracin M, Bonafè M, Zinzani PL, Bonifazi F. De Matteis S, et al. Among authors: messelodi d. Front Immunol. 2023 Jan 16;13:1058126. doi: 10.3389/fimmu.2022.1058126. eCollection 2022. Front Immunol. 2023. PMID: 36726971 Free PMC article.
Role of CBL Mutations in Cancer and Non-Malignant Phenotype.
Leardini D, Messelodi D, Muratore E, Baccelli F, Bertuccio SN, Anselmi L, Pession A, Masetti R. Leardini D, et al. Among authors: messelodi d. Cancers (Basel). 2022 Feb 8;14(3):839. doi: 10.3390/cancers14030839. Cancers (Basel). 2022. PMID: 35159106 Free PMC article. Review.
Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants.
Baccelli F, Leardini D, Muratore E, Messelodi D, Bertuccio SN, Chiriaco M, Cancrini C, Conti F, Castagnetti F, Pedace L, Pession A, Yoshimi A, Niemeyer C, Tartaglia M, Locatelli F, Masetti R. Baccelli F, et al. Among authors: messelodi d. Hum Genomics. 2022 Sep 19;16(1):40. doi: 10.1186/s40246-022-00414-y. Hum Genomics. 2022. PMID: 36123612 Free PMC article.
Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK).
Fiore M, Taddia A, Indio V, Bertuccio SN, Messelodi D, Serravalle S, Bandini J, Spreafico F, Perotti D, Collini P, Di Cataldo A, Pasquinelli G, Chiarini F, Fois M, Melchionda F, Pession A, Astolfi A. Fiore M, et al. Among authors: messelodi d. Int J Mol Sci. 2023 Feb 13;24(4):3743. doi: 10.3390/ijms24043743. Int J Mol Sci. 2023. PMID: 36835166 Free PMC article.
Gene Expression Landscape of SDH-Deficient Gastrointestinal Stromal Tumors.
Indio V, Schipani A, Nannini M, Urbini M, Rizzo A, De Leo A, Altimari A, Di Scioscio V, Messelodi D, Tarantino G, Astolfi A, Pantaleo MA. Indio V, et al. Among authors: messelodi d. J Clin Med. 2021 Mar 4;10(5):1057. doi: 10.3390/jcm10051057. J Clin Med. 2021. PMID: 33806389 Free PMC article.
Successful treatment of a chemotherapy-resistant t(17;19) paediatric ALL with a combination of inotuzumab, venetoclax and navitoclax.
Gottardi F, Baccelli F, Leardini D, Di Battista A, Castellucci P, D'Amico D, Serravalle S, Bertuccio SN, Messelodi D, Prete A, Masetti R. Gottardi F, et al. Among authors: messelodi d. Br J Haematol. 2023 Sep;202(5):e39-e42. doi: 10.1111/bjh.18936. Epub 2023 Jun 22. Br J Haematol. 2023. PMID: 37350036 No abstract available.
14 results